Table 5.
Ligand | WT mice |
S426A/S430A mice |
||
---|---|---|---|---|
Bmax (fmol/mg) | KD (nm) | Bmax (fmol/mg) | KD (nm) | |
Vehicle | 426 ± 42 | 1.60 ± 0.29 | 406 ± 62 | 1.69 ± 0.33 |
Δ9-THC | 231 ± 42* | 0.78 ± 0.23 | 253 ± 60 | 0.73 ± 0.28 |
Data are mean Bmax and KD values ± SEM (n = 5–6). Spinal cord membranes from vehicle- and THC-treated WT and S426A/S430A CB1 receptor knock-in mice were incubated with varying concentrations of [3H]CP55,940 with and without 5 μm unlabeled CP55,940 to measure nonspecific binding, as described in Materials and Methods. Saturation binding curves were fit by nonlinear regression.
*p < 0.05 different from vehicle-treated mice of the same genotype as determined by two-way ANOVA and planned comparison with Bonferroni post hoc test.